Emma Reeve's Net Worth
$4.04 Million
Who is Emma Reeve?
Emma Reeve has an estimated net worth of $4.04 Million. This is based on reported shares across multiple companies, which include CONSTELLATION PHARMACEUTICALS INC, Editas Medicine, Inc., Aadi Bioscience, Inc., PTC THERAPEUTICS, INC., and PAREXEL INTERNATIONAL CORP.
SEC CIK
Emma Reeve's CIK is 0001680329
Past Insider Trading and Trends
2020 was Emma Reeve's most active year for acquiring shares with 24 total transactions. Emma Reeve's most active month to acquire stocks was the month of January. 2020 was Emma Reeve's most active year for disposing of shares, totalling 38 transactions. Emma Reeve's most active month to dispose stocks was the month of April. 2019 saw Emma Reeve paying a total of $449,391.02 for 166,126 shares, this is the most they've acquired in one year. In 2020 Emma Reeve cashed out on 111,498 shares for a total of $2,519,190.97, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CONSTELLATION PHARMACEUTICALS INC No price found
Chief Financial OfficerEmma Reeve used to own units in Common Stock but no longer holds any shares there. In the year 2018 Emma Reeve filed a total of 18 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
$22.84 | -$304,020.60 |
0
|
Scheduled
|
Feb 19 - Feb 22
| ||
Form 4
|
—
|
0
|
$22.81 | -$44,600.50 |
0
|
Scheduled
|
Feb 17 - Feb 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
$20.96 | -$161,829.76 |
0
|
Scheduled
|
Dec 21
| ||
Form 4
|
—
|
0
|
$22.58 | -$17,641.16 |
0
|
Scheduled
|
Jun 8
| ||
Form 4
|
—
|
0
|
$29.43 | -$1,157,941.74 |
0
|
Scheduled
|
May 8 - May 11
| ||
Form 4
|
—
|
0
|
$20.95 | -$21,796.04 |
0
|
Scheduled
|
Apr 17
| ||
Form 4
|
—
|
0
|
$21.98 | -$32,391.69 |
0
|
Scheduled
|
Apr 14
| ||
Form 4
|
—
|
0
|
$21.40 | -$19,063.77 |
0
|
Scheduled
|
Apr 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
$21.55 | -$178,906.22 |
0
|
Scheduled
|
Feb 12 - Feb 13
| ||
Form 4
|
—
|
0
|
$21.36 | -$241,987.28 |
0
|
Feb 10 - Feb 11
| |||
Form 4
|
—
|
0
|
$14.13 | -$967,994.20 |
0
|
Scheduled
|
Nov 6
| ||
Form 4
|
—
|
0
|
$11.06 | -$8,894.00 |
0
|
Scheduled
|
Nov 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Editas Medicine, Inc. (EDIT) Snapshot price: $3.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aadi Bioscience, Inc. (AADI) Snapshot price: $1.82
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PTC THERAPEUTICS, INC. (PTCT) Snapshot price: $31.54
InvestorEmma Reeve owns 11,200 units of Common Stock which is worth $353,248.00. From 2018 to 2024 Emma Reeve acquired a total of 27,268 shares in PTC THERAPEUTICS, INC. at a cost of $425,064.16, Emma also disposed a total of 16,068 shares of PTC THERAPEUTICS, INC. equalling to $953,868.84.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +55.56% | 4K |
—
|
—
| 11.2K |
Feb 15
| |||
Form 4
|
—
|
0
|
$46.45 | -$255,510.59 | 7.2K |
May 22 - May 23
| |||
Form 4
| -37.54% | -4.33K |
$55.05 | -$238,258.09 | 7.2K |
Apr 21
| |||
Form 4
| +53.13% | 4K |
—
|
—
| 11.53K |
Jan 5
| |||
Form 4
| +73.94% | 3.2K |
—
|
—
| 7.53K |
Jan 7
| |||
Form 4
| +61.61% | 1.65K |
—
|
—
| 4.33K |
Jan 6
| |||
Form 4
| +62.30% | 1.03K |
$50.51 | -$35,036.00 | 2.68K |
Scheduled
|
Dec 14 - Dec 15
| ||
Form 4
|
∞
| 1.65K |
—
|
—
| 1.65K |
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PAREXEL INTERNATIONAL CORP No price found
Corp. VP & Interim CFOEmma Reeve owns 8,468 units of Common Stock. In the year 2016 Emma Reeve filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +38.37% | 2.35K |
—
|
—
| 8.47K |
Dec 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||